Evaluation of Access to Licensed Vaccines for High-Risk Infectious Diseases: A Comprehensive Review and Interpretive Analysis of Ebola Virus Disease - Top-Institutions - MDSpire

Evaluation of Access to Licensed Vaccines for High-Risk Infectious Diseases: A Comprehensive Review and Interpretive Analysis of Ebola Virus Disease

  • By

  • Charlot Diepvens

  • Donovan Guttieres

  • Kim De Boeck

  • Nico Vandaele

  • Leonor Guariguata

  • Catherine Decouttere

  • January 10, 2026

Share

Top Institutions in Infectious Disease

Brief introduction explaining scope and methodology.

  • #1

    Centers for Disease Control and Prevention (CDC)
    Centers for Disease Control and Prevention (CDC)

    Atlanta, GA

    Key Differentiators

    • Infectious Diseases
    • Epidemiology
    • Vaccine Research

  • #2

    National Institute of Allergy and Infectious Diseases (NIAID), NIH
    National Institute of Allergy and Infectious Diseases (NIAID), NIH

    Bethesda, MD

    Key Differentiators

    • Immunology
    • Vaccine Development
    • Infectious Diseases

  • #3

    World Health Organization (WHO) Collaborating Centers for Emerging Infectious Diseases
    World Health Organization (WHO) Collaborating Centers for Emerging Infectious Diseases

    Geneva, Switzerland

    Key Differentiators

    • Global Health
    • Infectious Disease Control
    • Vaccine Access

  • #4

    Institut National de Recherche Biomédicale (INRB)
    Institut National de Recherche Biomédicale (INRB)

    Kinshasa, DR Congo

    Key Differentiators

    • Infectious Diseases
    • Field Epidemiology
    • Vaccine Trials

  • #5

    Johns Hopkins Bloomberg School of Public Health
    Johns Hopkins Bloomberg School of Public Health

    Baltimore, MD

    Key Differentiators

    • Epidemiology
    • Global Health
    • Vaccine Policy

Original Source(s)

Evaluation of Access to Licensed Vaccines for High-Risk Infectious Diseases: A Comprehensive Review and Interpretive Analysis of Ebola Virus Disease

  • by Charlot Diepvens, Donovan Guttieres, Kim De Boeck, Nico Vandaele, Leonor Guariguata, Catherine Decouttere

  • January 10, 2026

Related Content

Tennessee's Ivermectin Experiment

Pharmacies expand access as oversight questions grow.

Covid vaccination cut risk of adverse heart events, large study finds

What if this Ebola outbreak can’t be stopped?